Elle est responsable, entre autres, du bon fonctionnement du systme nerveux, immunitaire et du bon fonctionnement du cur
The SURPASS-4 clinical trial was a non-inferiority study comparing tirzepatide to insulin glargine where tirzepartide showed superior A1c and body weight reductions from baseline in adults with T2DM at increased CVD risk.[20] Also, tirzepatide reported a higher occurrence of individuals achieving an A1c below 7% compared to insulin glargine
Aldini G, Vistoli G, Stefek M, Chondrogianni N, Grune T, Sereikaite J, et al
Benefits Seen in Various Research Settings Metabolic pathway signalling explored through controlled enzyme inhibition models
British Liver Trust
The third pathway: gut barrier support